|
1
|
Dong C and Hemminki K: Second primary
neoplasms among 53 159 haematolymphoproliferative malignancy
patients in Sweden, 1958–1996: a search for common mechanisms. Br J
Cancer. 85:997–1005. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Giroux DJ, Rami-Porta R, Chansky K, et al;
International Association for the Study of Lung Cancer
International Staging Committee. The IASLC Lung Cancer Staging
Project: data elements for the prospective project. J Thorac Oncol.
4:679–683. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sano H and Marugame T: International
comparisons of cumulative risk of lung cancer, from cancer
incidence in five continents. Vol VIII. Jpn J Clin Oncol.
36:334–335. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wakelee HA, Chang ET, Gomez SL, et al:
Lung cancer incidence in never smokers. J Clin Oncol. 25:472–478.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chansky K, Sculier JP, Crowley J, et al;
International Staging Committee and Participating Institutions. The
International Association for the Study of Lung Cancer Staging
Project: prognostic factors and pathologic TNM stage in surgically
managed non small cell lung cancer. J Thorac Oncol. 4:792–801.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Swerdlow SH, Campo E, Harris NL, et al:
World Health Organization Classification of Tumours of
Haematopoietic and Lymphoid Tissues. IARC Press; Lyon: 2008
|
|
7
|
Klein U and Dalla-Favera R: Germinal
centres: role in B-cell physiology and malignancy. Nat Rev Immunol.
8:22–33. 2008. View
Article : Google Scholar
|
|
8
|
Chawla-Sarkar M, Lindner DJ, Liu JF, et
al: Apoptosis and interferons: role of interferon-stimulated genes
as mediators of apoptosis. Apoptosis. 8:237–249. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ohno Z, Tamaki H, Ohsuga T, et al: Primary
lung carcinoma complicated by malignant lymphoma in two cases of
Epstein Barr virus infection. Case Rep Oncol. 5:367–372. 2012.
View Article : Google Scholar
|
|
10
|
Cui Y, Liu T, Zhou Y, et al: Five cases
report of solid tumors synchronously with hematologic malignancy.
Cancer Res Treat. 44:63–68. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Compostella A, Toffolutti T, Soloni P, et
al: Multiple synchronous tumors in a child with Fanconi Anemia. J
Pediatr Surg. 45:e5–e8. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kaneko S and Yamaguchi N: Epidemiological
analysis of site relationships of synchronous and metachronous
multiple primary cancers in the National Cancer Centers, Japan,
1962–1996. Jpn J Clin Oncol. 29:96–105. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Harris NL, Jaffe ES, Stein H, et al: A
revised European-American classification of lymphoid neoplasms: a
proposal from the International Lymphoma Study Group. Blood.
84:1361–1392. 1994.PubMed/NCBI
|
|
14
|
Goldstraw P, Crowley J, Chansky K, et al:
The IASLC Lung Cancer Staging Project: Proposal for the revision of
the TNM stage groupings in the forthcoming (seventh) edition of the
TNM classification of malignant tumours. J Thorac Oncol. 2:706–714.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jung CY and Kwon KY: A case of synchronous
lung adenocarcinoma and extranodal marginal zone B-cell lymphoma of
mucosa-associated lymphoid tissue (MALT) type. Tuber Resp Dis
(Seoul). 73:61–66. 2012. View Article : Google Scholar
|
|
16
|
Dores GM, Metayer C, Curtis RE, et al:
Second malignant neoplasms among long-term survivors of Hodgkin’s
disease: a population-based evaluation over 25 years. J Clin Oncol.
20:3484–3494. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hodgson DC, Koh ES, Tran TH, et al:
Individualized estimates of second cancer risks after contemporary
radiation therapy for Hodgkin lymphoma. Cancer. 110:2576–2586.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Groves FD, Linet MS, Travis LB and Devesa
SS: Cancer surveillance series: non-Hodgkin’s lymphoma incidence by
histologic subtype in the United states from 1978 through 1995. J
Natl Canc Instit. 92:1240–1251. 2000. View Article : Google Scholar
|
|
19
|
Harris NL, Jaffe E, Diebold J, et al:
World Health Organization classification of neoplastic diseases of
the hematopoietic and lymphoid tissues: Report of the Clinical
Advisory Committee Meeting-Arlie House, Virginia, November 1997. J
Clin Oncol. 17:3835–3849. 1999.PubMed/NCBI
|
|
20
|
Schmitz N, Pfistner B, Sextro M, et al:
Aggressive conventional chemotherapy compared with high-dose
chemotherapy with autologous haematopoietic stem-cell
transplantation for relapsed chemosensitive Hodgkin’s disease: a
randomised trial. Lancet. 359:2065–2071. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Enblad G, Glimelius B and Sundström C:
Treatment outcome in Hodgkin’s disease in patients above the age of
60: a population-based study. Ann Oncol. 2:297–302. 1991.PubMed/NCBI
|
|
22
|
Adami J, Frisch M, Yuen J, et al: Evidence
of an association between non Hodgkin’s lymphoma and skin cancer.
BMJ. 310:1491–1495. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shugart YY, Heminki K, Vaittinen P, et al:
A genetic study of Hodgkin’s lymphoma: an estimate of heritability
and anticipation based on the familial cancer database in Sweden.
Hum Genet. 106:553–556. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Capalbo S, Trerotoli P, Ciancio A, et al:
Increased risk of lymphoproliferative disorders in relatives of
patients with B-cell chronic lymphocitic leukemia: relevance of the
degree of familial linkage. Eur J haematol. 65:114–117. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cardous-Ubbink MC, Heinen PC, Bakker PJ,
et al: Risk of second malignancies in long-term survivors of
childhood cancer. Eur J Canc. 43:351–362. 2007. View Article : Google Scholar
|
|
26
|
Wiernik PH, Wang SQ, Hu XP, et al: Age of
onset evidence for anticipation in familial non Hodgkin’s lymphoma.
Br J Haematol. 108:72–79. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Travis LB, Curtis RE, Bennett WP, et al:
Lung cancer after Hodgkin’s disease. J Natl Cancer Inst.
87:1324–1327. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hemminki K and Vaittinen P: National
database of familial cancer in Sweden. Genet Epidemiol. 15:225–236.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Milatovich A, Travis A, Grosschedl R and
Francke U: Gene for lymphoid-enhancer-binding factor 1 (LEF1)
mapped to human chromosome 4 (q23–q25) and mouse chromosome 3 near
Egf. Genomics. 11:1040–1048. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Demirci U, Ozdemir N, Benekli M, et al:
Lymphoproliferative disorders in multiple primary cancers. Asian
Pac J Cancer Prev. 13:383–386. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Caillard S, Lelong C, Pessione F, et al:
Post-transplant lymphoproliferative disorders occurring after renal
transplantation in adults: report of 230 cases from the French
Registry. Am J Transplant. 6:2735–2742. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Enblad G, Glimelius B and Sundström C:
Treatment outcome in Hodgkin’s disease in patients above the age of
60: a population-based study. Ann Oncol. 2:297–302. 1991.PubMed/NCBI
|
|
33
|
Bassal M, Mertens AC, Taylor L, et al:
Risk of selected subsequent carcinomas in survivors of childhood
cancer: a report from Childhood Cancer Survivor Study. J Clin
Oncol. 24:476–483. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chanel S, Burke L, Fiche M, et al:
Synchronous pulmonary adenocarcinoma and extranodal marginal
zone/low-grade B-cell lymphoma of MALT type. Hum Pathol.
32:129–132. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Oikonomou A, Astrinakis E, Kotsianidis I,
et al: Synchronous BALT Lymphoma and Squamous Cell Carcinoma of the
Lung: Coincidence or Linkage? Case Rep Oncol Med Volume.
2013:4203932013.
|
|
36
|
Cui Y, Liu T, Zhou Y, et al: Five cases
report of solid tumor synchronously with hematologic malignancy.
Cancer Res Treat. 44:63–68. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Jung CY and Kwon KY: A Case of Synchronous
Lung Adenocarcinoma and Extranodal Marginal Zone B-Cell Lymphoma of
Mucosa-Associated Lymphoid Tissue MALT type. Tuberc Respir Dis
(Seoul). 73:61–66. 2012. View Article : Google Scholar
|
|
38
|
Cadranel J, Wislez M and Antoine M:
Primary pulmonary lymphoma. European Respiratory Journal.
3:750–762. 2002. View Article : Google Scholar
|
|
39
|
Visittsunthorn N, Utsawapreechawong W,
Pacharn P, et al: Immediate type hypersensitivity to
chemotherapeutic agents in pediatric patients. Asian Pac J Allergy
Immunol. 27:191–197. 2009.
|
|
40
|
Ganz PA: Late effects of cancer and its
treatment. Semin Oncol Nurs. 17:241–248. 2001. View Article : Google Scholar
|
